National Centre for Parasitology, Entomology and Malaria Control, Ministry of Health, 477 Betong Street (Corner St.92), Village Trapangsvay, Sanakat Phnom Penh Thmey, Khan Sensok, Phnom Penh, Cambodia.
Directorate General for Health, Ministry of Health, 80, Samdech Penn Nouth Blvd. (289), Sangkat Boeungkak 2, Tuol Kork District, Phnom Penh, Cambodia.
Infect Dis Poverty. 2018 Feb 20;7(1):15. doi: 10.1186/s40249-018-0394-7.
Endemicity of lymphatic filariasis (LF) in Cambodia was proven in 1956 when microfilariae were detected in mosquitos in the Kratié province. In 2001, an extensive study confirmed the presence of both Brugia malayi and Wuchereria bancrofti microfilariae. In 2003, the Ministry of Health established a national task force to develop policies and strategies for controlling and eliminating neglected tropical diseases (NTDs), with the goal of eliminating LF by 2015. This article summarizes the work accomplished to eliminate LF as a public health problem in Cambodia.
The National Program to Eliminate Lymphatic Filariasis made excellent progress in the goal towards elimination due to strong collaboration between ministries, intensive supervision by national staff, and advocacy for mobilization of internal and external resources. Mass drug administration (MDA) with diethylcarbamazine citrate and albendazole was conducted in six implementation units, achieving > 70% epidemiological coverage for five consecutive rounds, from 2005 to 2009. In 2006, in 14 provinces, healthcare workers developed a line list of lymphedema and hydrocele patients, many of whom were > 40 years old and had been affected by LF for many years. The national program also trained healthcare workers and provincial and district staff in morbidity management and disability prevention, and designated health centers to provide care for lymphedema and acute attack. Two reference hospitals were designated to administer hydrocele surgery.
Effectiveness of MDA was proven with transmission assessment surveys. These found that less than 1% of school children had antigenemia in 2010, which fell to 0% in both 2013 and 2015. A separate survey in one province in 2015 using Brugia Rapid tests to test for LF antibody found one child positive among 1677 children. The list of chronic LF patients was most recently updated and confirmed in 2011-2012, with 32 lymphoedema patients and 17 hydrocele patients listed. All lymphedema patients had been trained on self-management and all hydrocele patients had been offered free surgery.
Due to the success of the MDA and the development of health center capacity for patient care, along with benefits gained from socioeconomic improvements and other interventions against vector-borne diseases and NTDs, Cambodia was validated by the World Health Organization as achieving LF elimination as a public health problem in 2016.
1956 年在 KRATIÉ 省的蚊子中检测到微丝蚴,证实柬埔寨存在淋巴丝虫病(LF)地方性流行。2001 年,一项广泛的研究证实存在马来丝虫和班氏吴策线虫微丝蚴。2003 年,卫生部成立了一个国家工作队,制定控制和消除被忽视的热带病(NTD)的政策和战略,目标是到 2015 年消除 LF。本文总结了柬埔寨在消除 LF 作为公共卫生问题方面所做的工作。
国家消除淋巴丝虫病规划由于各部之间的密切合作、国家工作人员的密集监督以及动员内外资源的宣传,在实现消除目标方面取得了巨大进展。2005 年至 2009 年,在六个实施单位中进行了六轮乙胺嗪柠檬酸盐和阿苯达唑大规模药物治疗(MDA),连续五年实现了>70%的流行病学覆盖率。2006 年,在 14 个省,医务人员制定了淋巴水肿和鞘膜积液患者的名单,其中许多人年龄>40 岁,多年来一直受到 LF 的影响。国家规划还培训了医务人员以及省和地区工作人员进行发病率管理和残疾预防,并指定了卫生中心为淋巴水肿和急性发作提供护理。两家参考医院被指定进行鞘膜积液手术。
传播评估调查证明 MDA 的有效性。这些调查发现,2010 年在校儿童中抗原血症的比例不到 1%,2013 年和 2015 年均降至 0%。2015 年在一个省进行的一项单独调查使用 Brugia 快速检测来检测 LF 抗体,在 1677 名儿童中发现 1 名儿童呈阳性。最近一次更新并确认了慢性 LF 患者名单是在 2011-2012 年,列出了 32 名淋巴水肿患者和 17 名鞘膜积液患者。所有淋巴水肿患者都接受了自我管理培训,所有鞘膜积液患者都接受了免费手术。
由于 MDA 的成功以及卫生中心为患者提供护理的能力的发展,以及从社会经济改善和其他针对病媒传播疾病和 NTD 的干预措施中获得的收益,柬埔寨于 2016 年被世界卫生组织确认为实现 LF 消除作为公共卫生问题。